Several significant pledges for global health – covering reproductive health, ‘transition’ and Ebola – were made on the fringes of last week’s United Nations General Assembly amid massive donor withdrawal from the sector. Reproductive health, which has suffered massive funding losses, got a $337.8 million boost from the United Kingdom, which announced its pledge at […] Continue reading ->
With Thursday’s 24 September deadline looming, international scientific societies and civil society leaders are pushing Spain to sponsor a last-minute nomination of Dr María Neira as candidate in the World Health Organization (WHO) Director-General election. Neira is WHO’s former Director for Environment, Climate Change and Health, and her nomination has been endorsed by Nobel Peace […] Continue reading ->
A new modelling study suggests that US Medicare “Most-Favored-Nation” policies on drug prices would cut Medicare spending on brand-name drugs, but potentially incentivize companies to increase prices or delay new drug launches elsewhere. Efforts to control the cost of government spending on drugs culminated in a Most-Favored-Nation (MFN) policy, a Trump administration initiative which ties […] Continue reading ->
Country controversies, secret terms, opaque procurement, and massive unspent Congressional funds have characterised the first year of the America First Global Health Strategy.. “Services are weaker than they were a year ago, HIV testing is down, treatment of children living with HIV is down, and community-based prevention is gutted,” said Emily Bass, expert consultant for […] Continue reading ->